Juan Carlos Turriate Gastulo

Array ( [id] => 7325040 [patent_doc_number] => 20040138108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Pro-drug and use thereof as a medicament' [patent_app_type] => new [patent_app_number] => 10/474396 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9741 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138108.pdf [firstpage_image] =>[orig_patent_app_number] => 10474396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683886 [patent_doc_number] => 20030119750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Use of dipeptidyl peptidase IV inhibitors' [patent_app_type] => new [patent_app_number] => 10/126374 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19780 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119750.pdf [firstpage_image] =>[orig_patent_app_number] => 10126374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211540 [patent_doc_number] => 07622446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Polypeptides, derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/475281 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 10631 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622446.pdf [firstpage_image] =>[orig_patent_app_number] => 10475281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 501915 [patent_doc_number] => 07205435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Type B botulism toxin inhibitors' [patent_app_type] => utility [patent_app_number] => 10/474378 [patent_app_country] => US [patent_app_date] => 2002-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8433 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205435.pdf [firstpage_image] =>[orig_patent_app_number] => 10474378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567605 [patent_doc_number] => 20020165159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'FSH-releasing peptides' [patent_app_type] => new [patent_app_number] => 10/109331 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5065 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165159.pdf [firstpage_image] =>[orig_patent_app_number] => 10109331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851491 [patent_doc_number] => 20030143694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Long-acting follicle stimulating hormone analogues and uses thereof' [patent_app_type] => new [patent_app_number] => 10/112321 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8809 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143694.pdf [firstpage_image] =>[orig_patent_app_number] => 10112321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793269 [patent_doc_number] => 06982315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-03 [patent_title] => 'Process for the preparation of carboxamides' [patent_app_type] => utility [patent_app_number] => 10/108667 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 8457 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982315.pdf [firstpage_image] =>[orig_patent_app_number] => 10108667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310381 [patent_doc_number] => 20040142876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Peptides and their use as inhibitors of hepatitis c virus ns3 protease' [patent_app_type] => new [patent_app_number] => 10/473443 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31047 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142876.pdf [firstpage_image] =>[orig_patent_app_number] => 10473443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325026 [patent_doc_number] => 20040138102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Use of a substantially cell membrane impermeable compound for treating arthritis' [patent_app_type] => new [patent_app_number] => 10/472252 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 23337 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138102.pdf [firstpage_image] =>[orig_patent_app_number] => 10472252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 755118 [patent_doc_number] => 07019109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'SSTR1-selective analogs' [patent_app_type] => utility [patent_app_number] => 10/099240 [patent_app_country] => US [patent_app_date] => 2002-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14784 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/019/07019109.pdf [firstpage_image] =>[orig_patent_app_number] => 10099240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009528 [patent_doc_number] => 06900290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-31 [patent_title] => 'Fractionation of whey proteins by complex formation' [patent_app_type] => utility [patent_app_number] => 10/095856 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11805 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900290.pdf [firstpage_image] =>[orig_patent_app_number] => 10095856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7409573 [patent_doc_number] => 20040176284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis' [patent_app_type] => new [patent_app_number] => 10/469255 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5055 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176284.pdf [firstpage_image] =>[orig_patent_app_number] => 10469255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6555413 [patent_doc_number] => 20020164379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Oxygen-containing ophthalmic composition' [patent_app_type] => new [patent_app_number] => 10/070010 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10802 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164379.pdf [firstpage_image] =>[orig_patent_app_number] => 10070010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660145 [patent_doc_number] => 20030134789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues' [patent_app_type] => new [patent_app_number] => 10/083936 [patent_app_country] => US [patent_app_date] => 2002-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14343 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134789.pdf [firstpage_image] =>[orig_patent_app_number] => 10083936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074289 [patent_doc_number] => 20050147557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Diagnostic agents for pancreatic exocrine function' [patent_app_type] => utility [patent_app_number] => 10/482571 [patent_app_country] => US [patent_app_date] => 2002-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13616 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147557.pdf [firstpage_image] =>[orig_patent_app_number] => 10482571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7149759 [patent_doc_number] => 20040171066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Template-fixed peptidomimetics with antimicrobial activity' [patent_app_type] => new [patent_app_number] => 10/469060 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78800 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171066.pdf [firstpage_image] =>[orig_patent_app_number] => 10469060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 707854 [patent_doc_number] => 07060675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Methods of treating diabetes mellitus' [patent_app_type] => utility [patent_app_number] => 10/075097 [patent_app_country] => US [patent_app_date] => 2002-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 24 [patent_no_of_words] => 18651 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060675.pdf [firstpage_image] =>[orig_patent_app_number] => 10075097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 938452 [patent_doc_number] => 06972281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-06 [patent_title] => 'Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/068905 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 8980 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972281.pdf [firstpage_image] =>[orig_patent_app_number] => 10068905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788473 [patent_doc_number] => 20020160975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO for mediating apoptosis' [patent_app_type] => new [patent_app_number] => 10/068569 [patent_app_country] => US [patent_app_date] => 2002-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 26487 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160975.pdf [firstpage_image] =>[orig_patent_app_number] => 10068569 [rel_patent_id] =>[rel_patent_doc_number] =>)